EXECUTIVE ENGAGEMENTS
OUTREACH
5613
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
898
Interactions with Platform & by Email
PARTICIPANTS
168
Unique # Participated
VALIDATIONS
76
Responses Validated*
COMPETITORS
83
Responses Validated*
BRANDS
515
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
123
PAGES
236
EDITION
20
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. GC/CRT (Clinical), one of the segments analyzed in the report, is projected to record a 7% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the AISS (Clinical) segment is readjusted to a revised 3.2% CAGR for the next 7-year period.
The Automated and Rapid Microbiological Tests market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
In the global ABCS (Clinical) segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$306.5 Million in the year 2020 will reach a projected size of US$364.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027, while Latin America will expand at a 3.7% CAGR through the analysis period.
SELECT PLAYERS
Abbott Laboratories; Abbott Molecular; Alere Inc; Becton Dickinson and Company; bioMérieux SA; bioMerieux, Inc.; Bio-Rad Laboratories, Inc; Cellabs Pty Ltd.; CorisBioconcept SPRL; F. Hoffmann-La Roche AG; Hologic, Inc.; MedMira Inc.; Meridian Bioscience, Inc.; OraSure Technologies, Inc.; Orion Diagnostica Oy; Oxoid Limited; Quidel Corporation; Sekisui Diagnostics, LLC; Siemens Healthcare GmbH; Thermo Fischer Scientific Inc.
SEGMENTS
» Application (GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical), Non-Clinical)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Global In-Vitro Diagnostics Market |
| Central Laboratories Dominate the Market |
| Immunochemistry - the Leading Segment |
| Recent Market Activity |
| Automated and Rapid Microbiological Tests Revolutionize Microbiological Testing |
| Evolutionary Battle against Microbes Drives Market Future |
| Automated Microbiological Tests: A Pesky Gray Area in the Clinical Diagnostics Market |
| Instant Detection of Pathogens - A New Epoch in the Fight for Survival |
| Traditional Rapid Microbiological Tests Make Way for New, Probe Tests |
| Emerging Markets Provide Tremendous Growth Opportunities |
| Clinical Applications |
| Non-Clinical Applications |
| A Holistic Peek into a Few Noteworthy Trends |
| The Evolution of Biotechnology - A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests |
| Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Laboratories (US) |
| Abbott Molecular, Inc. (US) |
| Alere Inc. (US) |
| Beckman Coulter, Inc. (US) |
| Becton Dickinson and Company (US) |
| bioMérieux SA (France) |
| bioMerieux, Inc. (US) |
| Bio-Rad Laboratories, Inc (US) |
| Cellabs Pty Ltd (Australia) |
| Cepheid Inc. (US) |
| CorisBioconcept SPRL (Belgium) |
| F. Hoffmann-La Roche AG (Switzerland) |
| Hologic, Inc. (US) |
| MedMira Inc. (Canada) |
| Meridian Bioscience, Inc. (US) |
| OraSure Technologies, Inc. (US) |
| Orion Diagnostica Oy (Finland) |
| QIAGEN N.V. (The Netherlands) |
| Quidel Corporation (US) |
| Sekisui Diagnostics, LLC (US) |
| Siemens Healthcare GmbH (Germany) |
| Thermo Fisher Scientific Inc. (US) |
| Oxoid Limited (UK) |
| 3. MARKET TRENDS & DRIVERS |
| Increasing Incidence of Infectious Diseases - An Opportunity Indicator |
| Rising Healthcare Needs of Aging Global Population - A Growth Driver |
| The World is Ageing |
| Rising HIV Prevalence - A Key Opportunity Indicator |
| Some Significant HIV Statistics by Region: 2015 |
| Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease |
| Ultra-Rapid HIV-Screening Tests put up a Strong Fight against HIV-Epidemic |
| Accuracy/Reliability of Home HIV Testing: A Bone of Contention |
| Increase in Healthcare Spending in Emerging Markets to Propel Demand |
| Rising Emphasis on Lab Automation to Augur Well for Market Growth |
| Greater Patient Awareness to Drive Growth |
| Advancements in Molecular Diagnostics - A Boon |
| Antibiotic Resistant Bacteria Throws the Spotlight on Microbial Testing |
| Influenza - Boosting Rapid Test Prospects |
| Select FDA-approved Rapid Detection Tests for Flu A&B: (2015) |
| Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia |
| Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia |
| Impact of Food Scares on Rapid Microbiological Tests Market |
| Stringent Norms Necessitate Microbial Food Safety Testing |
| Rapid Screening Gains Preference over Traditional Food Testing Procedures |
| Conventional Testing Continues to Dominate but Rapid Tests Making Inroads |
| Leading Food Processors Resort to Rapid Microbiological Testing |
| Food Packages of the Future Ingrained with Microbial Alert Systems |
| Poultry Industry Embraces Rapid Microbiological Testing Technologies |
| Rapid Microbiological Tests Gain Significance in the Pharma Industry |
| Key Advantages of Rapid Microbiological Tests for Pharma- In a Nutshell |
| Growth Direct™ System Creates Waves in Pharmaceutical Quality Control |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for GC/CRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for AISS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for ABCS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for SIRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for ATS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Non-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 83 |
The U.S. Economy is Reinventing Itself to Weather Economic Storms.
Here's An Analytical Window into the Changing Opportunities.
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com